NFLX outshines PARA with robust growth, expanding global footprint, and clear profitability path, Investors can choose NFLX for superior returns in 2025.
|
![]() |
NFLX outshines PARA with robust growth, expanding global footprint, and clear profitability path, Investors can choose NFLX for superior returns in 2025.
|
![]() |
Investors would do well to monitor broker-favored stocks like BTSG, BYON, ACDVF, DINO, and EBS for high returns.
|
![]() |
65% off the highs: Is BBAI stock too risky for investors in 2025?
|
![]() |
MCD benefits from robust global expansion plans and solid digital and loyalty strategies.
|
![]() |
ECL continues to gain from its robust product portfolio and strong segmental performance.
|
![]() |
Globant's Q1 performance reflects steady top-line growth and margins driven by AI tailwinds amid macroeconomic headwinds, fueling a cautious spending approach.
|
![]() |
GE HealthCare launches CleaRecon DL, an AI-powered 3D imaging tech that enhances cone-beam CT scans by reducing artifacts, improving clarity for better interventional care.
|
![]() |
NBIS benefits from expanding infrastructure offerings, but intense competition from tech behemoths and macroeconomic challenges remain concerns.
|
![]() |
GILT's Q1 2025 performance is likely to have benefited from a surge in defense deals, momentum in its IFC business and steady gains from acquisition synergies.
|
![]() |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
|
![]() |